Use of postmenopausal hormone replacement therapy: Estimates from a nationally representative cohort study

American Journal of Epidemiology

Volumn 145, Issue 6, 1997, Pages 536-545

  Brett, Kate M ^a   Madans, Jennifer H ^a  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

cohort studies; estrogen replacement therapy; menopause; risk factors

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; FEMALE; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; RISK BENEFIT ANALYSIS; RISK FACTOR;

EID: 15644370220     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009142     Document Type: Article

References (39)

1. Scalley EK, Henrich JB. An overview of estrogen replacement therapy in postmenopausal women. J Women's Health 1993; 2:289-94.
2. Smith DC, Prentice R, Thompson DJ, et al. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975;293:1164-7.
3. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975; 293:1167-70.
4. Hemminki E, Kennedy DL, Baum C, et al. Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-1986. Am J Public Health 1988;78:1478-81.
5. Barrett-Connor E, Wingard DL, Criqui MH. Postmenopausal estrogen use and heart disease risk factors in the 1980s: Rancho Bernardo, Calif, revisited. JAMA 1989;261: 2095-2100.
6. Rosenberg L. Hormone replacement therapy: the need for reconsideration. Am J Public Health 1993;83:1670-3.
7. Kennedy DL, Baum C, Forbes MB. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol 1985;65:441-6.
8. Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol 1995;85:6-10.
9. Ernster VL, Bush TL, Huggins GR, et al. Benefits and risks of menopausal estrogen and/or progestin hormone use. Prev Med 1988;17:201-23.
10. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
11. Hunt K, Vessey M, McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 1990;97:1080-6.
12. Lindsay R, Cosman F, Nieves J. Estrogen: effects and actions in osteoporosis. Osteoporosis Int 1993;3(Suppl 1):S150-2.
13. Steinberg KK, Thacker SB, Smith SJ, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985-90.
14. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Framingham Study. N Engl J Med 1985; 313:1038-43.
15. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-9.
16. Criqui MH, Suarez L, Barrett-Connor E, et al. Postmenopausal estrogen use and mortality: results from a prospective study in a defined, homogeneous community. Am J Epidemiol 1988; 128:606-14.
17. Egeland GM, Matthews KA, Kuller LH, et al. Characteristics of noncontraceptive hormone users. Prev Med 1988;17:403-11.
18. Harris RB, Laws A, Reddy VM, et al. Are women using postmenopausal estrogen? A community survey. Am J Public Health 1990;80:1266-8.
19. Cauley JA, Cummings SR, Black DM, et al. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438-44.
20. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325:756-62.
21. Derby CA, Hume AL, Barbour MM, et al. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol 1993;137:1125-35.
22. Johannes CB, Crawford SL, Posner JG, et al. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994;140:439-52.
23. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;115:455-6.
24. Posthuma WFM, Westendorp RGJ, Vandenbroucke JP. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ 1994;308:1268-9.
25. Rosenberg L, Palmer JR, Shapiro S. A case-control study of myocardial infarction in relation to use of estrogen supplements. Am J Epidemiol 1993;137:54-63.
26. Duncan MH. Hormone replacement therapy: cardioprotective effect is genuine. (Letter). BMJ 1994;309:191.
27. Stevenson JC, Baum M. Hormone replacement therapy should be used selectively. (Letter). BMJ 1994;309:191.
28. Rosenberg L, Shapiro S, Kaufman DW, et al. Patterns and determinants of conjugated estrogen use. Am J Epidemiol 1979;109:676-86.
29. Cohen BB, Barbano HE, Cox CS, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1982-84. Hyattsville, MD: National Center for Health Statistics, 1987. (Vital and health statistics, Series 1: Programs and collection procedures, no. 22) (DHHS publication no. (PHS) 87-1324).
30. Finucane FF, Freid VM, Madans JH, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1986. Hyattsville, MD: National Center for Health Statistics, 1990. (Vital and health statistics, Series 1: Programs and collection procedures, no. 25) (DHHS publication no. (PHS) 90-1307).
31. Cox CS, Rothwell ST, Madans JH, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1987. Hyattsville, MD: National Center for Health Statistics, 1992. (Vital and health statistics, Series 1 : Programs and collection procedures, no. 27) (DHHS publication no. (PHS) 92-1303).
32. Dillman DA. Mail and telephone surveys: the total design method. New York: John Wiley & Sons, 1978.
33. Kleinman JC, Donahue RP, Harris MI, et al. Mortality among diabetics in a national sample. Am J Epidemiol 1988;128:389-401.
34. Ingram DD, Makuc MD. Statistical issues in analyzing the NHANES I Epidemiologic Followup Study. Hyattsville, MD: National Center for Health Statistics, 1994. (Vital and health statistics, Series 2: Data evaluation and methods research, no. 121) (DHHS publication no. (PHS) 94-1395).
35. Shah BV, Barnwell BG, Bieler GS. SUDAAN user's manual: software for analysis of correlated data, release 6.40. Research Triangle Park, NC: Research Triangle Institute, 1995.
36. Goodman MT, Nomura AMY, Wilkens LR, et al. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990;131:815-25
37. Jannausch ML, Sowers MR. Consistency of perimenopausal estrogen use reporting by women in a population-based prospective study. Maturitas 1992;14:161-9.
38. Darrow SL, Russell M, Cooper ML, et al. Sociodemographic correlates of alcohol consumption among African-American and white women. Women Health 1992;18:35-51.
39. Nabulsi AA, Folsom AR, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328:1069-75.